Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort.

Authors :: Hamy AS
Belin L
Bonsang-Kitzis H
Paquet C
Pierga JY
Lerebours F
Cottu P
Rouzier R
Savignoni A
Lae M
Reyal F
Source :: British journal of cancer [Br J Cancer] 2018 Mar 20; Vol. 118 (6), pp. e14. Date of Electronic Publication: 2018 Feb 20.
Publication Year :: 2018
Abstract: This corrects the article DOI: 10.1038/bjc.2017.85.

Full Text Access

Tools